?Acute Myocardial Infarecthion. Myocarditis in diseases classified elsewhere
Conditions
Interventions
Intervention 1: Aromatherapy start in the second and third days after the attack of acute hemodynamic conditions are Bymarpaydar is and will continue to DAY fourth after admission. For those in the in
Treatment - Drugs
Placebo
Aromatherapy start in the second and third days after the attack of acute hemodynamic conditions are Bymarpaydar is and will continue to DAY fourth after admission. For those in the intervention group
For patients in the placebo group (n = 40) of sunflower oil will be used. each time for 20 minutes is performed.
Sponsors
Lorestan University of Medical Sciences
Lorestan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: age 18-60 years old; a definite diagnosis of acute heart attack by a physician, and her EC endorsing a heart attack; DNR heart; lung at admission; no history of allergic rhinitis, eczema or respiratory problems such as asthma or chronic obstructive pulmonary disease known; Lack of sense of smell and taste disorders. Lack of medical disorders or uncontrolled contagious. being aware of the time and place and people. Lack of mental illness known. with no history of head injury or seizures. along with a disturbing lack of sleep disorders such as migraine, rheumatoid arthritis, breathing problems at night. having a drug addiction. stable vital signs. having no pain at the time of interview and questionnaire. insensitivity to smell the fragrances; score of more than 20% of Anxiety Inventory (STAI) and the fatigue score between 20 -100 questionnaire MFI-20. Exclusion criteria: the patient's unwillingness to continue the study; cardiogenic shock, cardiac arrest; lung and heart attack this time intervention; a decreased level of consciousness during intervention; the risk of heart rhythm, ventricular fibrillation and cardiogenic shock during the intervention; The use of benzodiazepines, analgesics and anti-anxiety for at least ten hours before the intervention and after the intervention; The use of complementary medicine Sayrdrman for at least a week before the intervention; The incidence of allergic and respiratory dysrhythmias and problems the intervention hemodynamically unstable time intervention patient died before the completion of the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anexity. Timepoint: Half an hour before and 15 minutes after intervention, twice a day. Method of measurement: Questionnaire using the Spielberger.;Fatigue. Timepoint: Half an hour before and half an hour after treatment, twice a day. Method of measurement: Using the questionnaire fatigue Mfi. | — |
Secondary
| Measure | Time frame |
|---|---|
| Headache. Timepoint: An hour after intervention. Method of measurement: Ask the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRaziehShirzadegan
Lorestan University of Medical Sciences
Outcome results
None listed